- 如果您对该产品感兴趣的话,可以
- 产品名称:075400IonPac AG20保护柱前处理柱美国戴安Dionex
- 产品型号:
- 产品展商:其它品牌
- 产品文档:无相关文档
- 发布时间:2016-05-11
- 在线询价
简单介绍
【简单介绍】IonPac AG20保护柱前处理柱美国戴安Dionex,上海希言科学仪器有限公司主要的代理产品品牌有:美国perkinelmer、美国戴安Dionex、德国duranDURAN、美国哈希Hach、美国沃特世Waters、美国安捷伦Agilent、德国贺利氏Heraeus、美国奥立龙Orion等知名品牌。
产品描述
IonPac AG20保护柱前处理柱美国戴安Dionex
IonPac AS20 Anion-Exchange Column Specifications |
---|
Maximum Operating Pressure: | 4000 psi (standard and microbore) 5000 psi (capillary) |
Mobile Phase Compatibility: | pH 0–14; 0–100% HPLC solvents |
Ion Exchange Group: | Functional Group: Alkanol quaternary ammonium ion |
Column Construction: | PEEK with 10–32 threaded ferrule style end fittings. All components are nonmetallic. |
Functional Group Characteristics: | Ultralow Hydrophobicity |
Dimensions: | IonPac AS20 Capillary Column: 0.4 ×250 mm IonPac AG20 Capillary Guard Column: 0.4 × 50 mm IonPac AS20 Analytical Column: 2 × 250 mm IonPac AG20 Guard Column: 2 × 50 mm IonPac AS20 Analytical Column: 4 × 250 mm IonPac AG20 Guard Column: 4 × 50 mm
|
Capacity: | 3.1 ?eq (0.4 × 250 mm capillary column) 77.5 ?eq (2 × 250 mm analytical column) 310 ?eq (4 × 250 mm analytical column) 0.06 ?eq*(0.4 × 50 mm capillary guard column) 1.5 ?eq* (2 × 50 mm guard column) 6 ?eq* (4 × 50 mm guard column) *Guards are packed with a low-capacity microporous resin. |
Substrate Characteristics: | Bead Diameter and Pore Size: 7.5 ?m (2 × 250, 4 × 250 and 0.4 × 250 mm); super macroporous resin (2000 ?) 11 ?m (2 × 50, 4 × 50 and 0.4 × 50 mm); microporous resin (<1 ?) Crosslinking (%DVB): 55% |
Analytical Columns |
---|
IonPac AS20 Analytical Column (2 x 250 mm) | 063065 |
IonPac AS20 Analytical Column (4 x 250 mm) | 063148 |
IonPac AS20 Capillary Column (0.4 x 250 mm) | 075399 |
Guard Columns |
---|
IonPac AG20 Guard Column (2 x 50 mm) | 063066 |
IonPac AG20 Guard Column (4 x 50 mm) | 063154 |
IonPac AG20 Capillary Guard Column (0.4 x 50 mm) | 075400 |
IonPac AG20保护柱前处理柱美国戴安Dionex,IonPac AG20保护柱前处理柱美国戴安Dionex
- 温馨提示:为规避购买风险,建议您在购买前务必确认供应商资质与产品质量。
- 免责申明:以上内容为注册会员自行发布,若信息的真实性、合法性存在争议,平台将会监督协助处理,欢迎举报